Essilor International
Clinical trials sponsored by Essilor International, explained in plain language.
Now part of
EssilorLuxottica SA
EL
EURONEXT PARIS
Ophthalmic optics company, part of EssilorLuxottica.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can special lenses slow nearsightedness in kids? Results expected Sep 2026 (estimated)
- Myopia glasses may keep working even after kids take them off Results expected Oct 2026 (estimated)
- Scientists watch how we look at screens – no cure, just curiosity Results expected Oct 2026 (estimated)
- New spectacle lenses aim to make myopia control more comfortable for kids Results expected Oct 2026 (estimated)
- New study tracks teen gaze to fight nearsightedness Results expected May 2027 (estimated)